Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy. [electronic resource]
Producer: 20180214Description: 529-538 p. digitalISSN:- 1533-4406
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Area Under Curve
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Exanthema -- chemically induced
- Female
- Human T-lymphotropic virus 1 -- isolation & purification
- Humans
- Male
- Middle Aged
- Paraparesis, Tropical Spastic -- drug therapy
- Receptors, CCR4 -- antagonists & inhibitors
- T-Lymphocytes -- immunology
- Viral Load
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.